多发性骨髓瘤风险调整治疗:评估当前潜力和未来路线图
1Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Leukemia & lymphoma
|December 22, 2024
概括
新的治疗方法已经延长了标准风险多发性骨髓瘤 (MM) 的生存期,但高风险MM (HRMM) 仍然显示出有限的益处. 本综述审查了适应风险的策略,以改善HRMM患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 多发性骨髓瘤 (MM) 治疗方法已经进步,标准风险患者的存活率提高到十多年.
- 高风险MM (HRMM) 的存活率仍然有限 (3-5年),需要新的治疗方法.
- HRMM的定义正在不断发展,包括基因组特征,疾病负担和并发症.
研究的目的:
- 审查当前关于多发性骨髓瘤患者风险适应治疗策略的证据.
- 探索管理高风险多发性骨髓瘤的最新进展和正在进行的调查.
主要方法:
- 对高风险MM的最近单臂第二阶段试验的审查.
- 对HRMM不断变化的定义和风险分层工具的分析.
- 在治疗策略中对最小残留疾病 (MRD) 测试的调查.
主要成果:
- 标准风险的MM显示,使用新药物显著增加了生存率.
- 高风险的MM生存益处不那么明显,突出显示了尚未满足的需求.
- 针对HRMM,正在研究强化治疗方法和MRD引导的降级.
结论:
- 风险适应性治疗对于优化多发性骨髓瘤治疗至关重要.
- 需要进一步的研究来完善HRMM的定义和治疗方案.
- 最小残留疾病监测可以指导MM的未来治疗决策.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.0K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.2K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
